Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01156129 · ClinicalTrials.gov registry record · Phase 1
Interventions to Decrease the Impact of Post-OPerative Ileus After Liver Transplant or Resection Surgery
A Phase 1 study, sponsored by University of Nebraska.
- Completed
- Registry status
- Phase 1
- Development phase
- 111
- Enrollment target
NCT01156129 is a Phase 1 study that has completed, run by University of Nebraska. The registered enrollment target is 111 participants.
The verdict
NCT01156129, a Phase 1 study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 111 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to assess ways to address post-operative ileus (POI) in adult patients on the liver transplant service undergoing either liver transplant or resection surgery. Patient who speak and understand English will be randomized into one of three groups including a.)control group receiving standard therapy for post-operative ileus, b.)group receiving standard therapy and acupressure bracelets, and c.)group receiving standard therapy and sugar free gum four times daily.
Interventions
- DRUG stool softener
- DEVICE Arm B: Acupressure bracelet
- DIETARY_SUPPLEMENT sugar free gum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2010-09-01 |
| Est. Completion | 2012-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01156129
The ClinicalTrials.gov registry entry for NCT01156129 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which stool softener is the first listed.
NCT01156129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01156129 about?
NCT01156129 is a clinical study titled "Interventions to Decrease the Impact of Post-OPerative Ileus After Liver Transplant or Resection Surgery". This is a randomized controlled trial to assess ways to address post-operative ileus (POI) in adult patients on the liver transplant service undergoing either liver transplant or resection surgery. Patient who speak and understand English will be randomized into one of three groups including a.)cont...
What is the current status of trial NCT01156129?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 111 participants. The study started on 2010-09-01. Estimated completion is 2012-12-01.
What interventions are being tested in trial NCT01156129?
The interventions under investigation include: stool softener (DRUG), Arm B: Acupressure bracelet (DEVICE), sugar free gum (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01156129?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.